Dr. Reddy's Laboratories Ltd. (RDY)
13.60
+0.05
(+0.37%)
USD |
NYSE |
May 22, 16:00
13.60
0.00 (0.00%)
After-Hours: 20:00
Dr. Reddy's Laboratories EPS Diluted (Quarterly) : 0.0288 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 1.709 |
| Teva Pharmaceutical Industries Ltd. | 0.3121 |
| Zai Lab Ltd. | -0.4621 |
| Eli Lilly & Co. | 8.255 |
| Concord Medical Services Holdings Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.09M |
| Revenue (Quarterly) | 821.02M |
| Total Expenses (Quarterly) | 796.98M |
| Enterprise Value | 11.25B |
| Gross Profit Margin (Quarterly) | 44.82% |
| Profit Margin (Quarterly) | 2.93% |
| Earnings Yield | 4.32% |
| Operating Earnings Yield | 4.70% |